Synergistic antitumor effect of resveratrol and sorafenib on hepatocellular carcinoma through PKA/AMPK/eEF2K pathway

Although sorafenib (Sor) is the only effective drug for hepatocellular carcinoma (HCC), its therapeutic potential to date is mainly limited to the low tumor response. This study was designed to explore whether resveratrol (Res) could potentiate the anticancerous activity of Sor. We used HepG2 and Hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Meili, Deng, Chun, Dang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Academia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559449/
https://www.ncbi.nlm.nih.gov/pubmed/34776832
http://dx.doi.org/10.29219/fnr.v65.3602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559449/
https://www.ncbi.nlm.nih.gov/pubmed/34776832
http://dx.doi.org/10.29219/fnr.v65.3602

Ejemplares similares